The US Food and Drug Administration has granted accelerated approval to Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed ...
The US Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease (SCD) with recurrent ...
Three in 10 young adults do not have a primary care doctor, according to the results of a survey released June 29 by The Ohio State University Wexner Medical Ce ...
A class II FDA recall of generic prednisolone acetate ophthalmic suspension eye drops was issued due to the presence of a foreign substance.
Older adults with a new prescription for a sedative have an increased risk for falls and adverse events in the 30 days after discharge.
Ophthalmic ambulatory surgical centers face financial challenges under Medicare facility fee reimbursements for high-cost procedures.
Prolonged sedentary behavior (SB) is associated with cancer mortality, according to a study published online July 2 in PLOS Medicine. Ziyi Zhou, Ph.D., from the ...
Americans often engage with health-related information on social media platforms, but express limited confidence in its accuracy.
Lumvoa (veligrotug-vvze) is now FDA-approved to treat thyroid eye disease regardless of activity or duration, offering a new therapeutic option for both active and chronic phases. The Food and Drug ...
Sugar-sweetened beverage (SSB) and fruit juice intake is associated with increased risk of hypertension, according to a study published online June 22 in Circul ...
The AAO recognizes visual electrophysiology as a useful adjunct in select glaucoma cases when structural and functional tests do not match.
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposures reported to U.S. poison centers increased following 2021 U.S. Food and Drug Administration (FDA) approval for weight loss. HealthDay News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results